<p>Crystallization, the final isolation and purification step
in many drug substance manufacturing processes, has substantial impact on
downstream efficiency and possibly final drug product qualities. Currently,
crystallization is largely carried out in batch which may suffers from
batch-to-batch variations. Continuous crystallization is the missing key to
end-to-end continuous manufacturing of oral solid dosage form pharmaceuticals.
It is estimated that shifting from batch to continuous operations may help the
pharmaceutical industry (1) reduce plant footprint, (2) decrease energy consumption
and (3) spawn faster response to drug shortages. The overall aim of this thesis
is to study and design continuous crystallization processes in both a
traditional stirred tank crystallizer (STC) and a novel oscillatory baffle
reactor (OBR). In the STC, the thesis aims to establish a systematic framework
to model crystallization via a risk-based approach. This methodology considers
the highly regulated nature of the pharmaceutical industry where an impactful
model must be verified and validated carefully. The OBR on the other hand is a
novel commercial platform in which continuous operations have never been
established. Its performance was compared to the STC in terms of residence time
distribution where OBR showed more uniform and consistent operation. A start-up
study was then carried out to study different start-up strategies to examine
their effects on process dynamics and steady state products. The last piece is
to study the integration of continuous crystallization with continuous
filtration which is not well studied in the current literature. A novel
commercial continuous filtration unit, the continuous filtration carousel (CFC)
was studied to construct a truly continuous drug substance separation step. The
operating conditions were optimized based on filter capacity and filter
efficiency studies with particles of different shapes. Continuous coupling of
crystallization and CFC was successfully carried out based on the optimized
conditions and a risk consideration discussion was given for process safety
assessments. </p>